Moderna Inc
(MRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,862,000 | 5,084,000 | 3,364,000 | 4,749,000 | 6,066,000 |
| Cost of Goods | 792,000 | 1,918,000 | 1,100,000 | 1,381,000 | 1,017,000 |
| Gross Profit | 1,070,000 | 3,166,000 | 2,264,000 | 3,368,000 | 5,049,000 |
| Operating Expenses | 1,436,000 | 1,586,000 | 1,098,000 | 921,000 | 822,000 |
| Operating Income | -366,000 | 1,580,000 | 1,166,000 | 2,447,000 | 4,227,000 |
| Other Income | 61,000 | 75,000 | 51,000 | 27,000 | 2,000 |
| Pre-tax Income | -305,000 | 1,655,000 | 1,217,000 | 2,474,000 | 4,229,000 |
| Income Tax | -384,000 | 190,000 | 174,000 | 277,000 | 572,000 |
| Net Income Continuous | 79,000 | 1,465,000 | 1,043,000 | 2,197,000 | 3,657,000 |
| Net Income | $79,000 | $1,465,000 | $1,043,000 | $2,197,000 | $3,657,000 |
| EPS Basic Total Ops | 0.20 | 3.95 | 2.67 | 5.55 | 9.09 |
| EPS Basic Continuous Ops | 0.20 | 3.90 | 2.67 | 5.55 | 9.10 |
| EPS Diluted Total Ops | 0.19 | 3.77 | 2.53 | 5.24 | 8.58 |
| EPS Diluted Continuous Ops | 0.20 | 3.74 | 2.53 | 5.24 | 8.58 |
| EBITDA(a) | $-305,000 | $1,656,000 | $1,285,000 | $2,534,000 | $4,324,000 |